🇺🇸 thyrotropin-releasing hormone in United States

6 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 1 report (16.67%)
  2. Illness — 1 report (16.67%)
  3. Obstructive Airways Disorder — 1 report (16.67%)
  4. Salivary Hypersecretion — 1 report (16.67%)
  5. Status Epilepticus — 1 report (16.67%)
  6. Toxicity To Various Agents — 1 report (16.67%)

Source database →

Other Endocrinology approved in United States

Frequently asked questions

Is thyrotropin-releasing hormone approved in United States?

thyrotropin-releasing hormone does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for thyrotropin-releasing hormone in United States?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is the originator. The local marketing authorisation holder may differ — check the official source linked above.